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ABSTRACT
Background: Leber hereditary optic neuropathy (LHON) is an inherited visual loss and optic 
atrophy due to mitochondrial mutation. Most of these patients had not any other neurological 
signs and symptoms more than a visual loss. In a small group of the patients, other neurological 
manifestations may be occurs. This rare presentation of the disease was named “ LHON 
plus syndromes.” Case Presentation: A 15-year-old boy who was completely healthy until 
age 9, when he gradually developed painless visual loss in his right eye. After 3 months, similar 
symptoms occurred in his left eye. Within next 2 years, psychomotor regression happened, and 
at age 11, very intractable seizures were started. According to physical examination and past 
medical history, LHON plus syndrome was diagnosed for him. Management of seizure and other 
symptomatic treatments were started, and there was a weak response to drugs. Conclusion: Early 
diagnosis and ruling out treatable conditions are critical points in these patients.
INTRODUCTION
Leber hereditary optic neuropathy (LHON) is a maternally 
inherited loss of central vision with optic atrophy due to mi-
tochondrial DNA (mtDNA) mutations. This syndrome is of-
ten found in male adolescents. In most of the patients, there 
are no other neurological manifestations (more than vision 
loss), and cerebral imaging is normal. However, some rare 
cases of LHON have been described with variable central 
nervous system (CNS) involvements. These cases called 
LHON plus syndrome (1). Overall, LHON is not a common 
condition, and LHON plus syndrome is very rare. Regarding 
current literature, there were only 7 similar cases to LHON 
plus syndrome with variable manifestations. Patients with 
LHON plus syndrome presented with vision loss and some 
other neurological manifestations such as dystonia, Parkin-
sonism, cerebellar ataxia, myoclonus, epilepsy, migraine, 
and mental retardation (2). There is no definite treatment for 
this condition, and symptomatic treatment is recommended 
in most of the patients. Herein we report a 15-year-old boy 
with LHON plus syndrome. To the best of our knowledge, 
this is the first report from Iran.
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CASE PRESENTATION
The patient was a 15-year-old boy who referred to neurol-
ogy ward from southern Iran (Bushehr Province). He was 
completely healthy until age 9 when gradually developed 
painless vision loss in his right eye. After three months, vi-
sion loss in his left eye was started. Funduscopy examination 
at the beginning of vision loss showed a hyperaemic optic 
nerve, telangectatic and tortuous peripapillary vessels. In our 
ward, his visual acuity was no light perception in both eyes. 
On slit-lamp examinations, the cornea, anterior chamber, 
and lens were normal. Severe optic atrophy, telangiectatic 
vessels, and retinitis pigmentosa were detected in the reti-
na of both eyes (Figure 1). Neurological examinations were 
within normal ranges. Neuro imaging studies were normal. 
The patient was born full-term, with normal development 
until age 9. After visual loss in both eyes, the patient devel-
oped psychomotor regression, and in age 11 the patient was 
considered as mentally retarded. At age 11, very intractable 
seizures began. The patient had recurrent episodes of ton-
ic-clonic seizures which were poorly controlled with several 
anti-convulsants. (sodium valproate, levetiracetam and lam-
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otrigine were used with very weak response). Family history 
was not significant.
Routine laboratory investigations, such as complete 
blood count, liver, kidney, and thyroid function tests were 
within normal ranges. Ammonia and lactate levels, autoan-
tibodies (i.e., anti ds DNA antibodies, antineutrophil cyto-
plasmic antibodies (ANCA) and neuro myelitis optica-IgG 
(NMO)), serology for an infectious cause such as Lyme dis-
ease, syphilis, herpes virus, and human immune deficiency 
virus (HIV) were all negative.
Visual evoked potential in both eyes was flat. Magnetic 
resonance imaging (MRI) of brain and orbit were normal. 
Electrocardiography (ECG) and echocardiography were 
normal. Electroencephalography showed nonspecific dif-
fuse cerebral dysfunction. Multiple sclerosis (MS), isch-
emic optic neuropathies, other mitochondrial disorders or 
an overlap syndrome such as Harding’s disease were in 
differential diagnosis which were ruled out during inves-
tigations. According to history and physical examination 
LHON plus syndrome was diagnosed for him. Other possi-
ble diagnoses included late-onset MS, ischemic optic neu-
ropathies, a mitochondrial disorder or an overlap syndrome 
such as Harding’s disease.
DISCUSSION
LHON is a maternally inherited disorder which is seen 
in male adolescents. This condition is characterized by 
the bilateral painless visual loss that typically progresses 
over weeks to months. Three different mtDNA mutations: 
G3460A, G11778A, and T14484C, in the ND1, ND4 and 
ND6 genes, (all encoding for complex I subunits of the mito-
chondrial respiratory chain) are associated with LHON phe-
notype (3). Several reports suggested different environmen-
tal causes such as smoking, alcohol abuse, exposure to some 
especial toxins, uncontrolled blood sugar (in diabetes), trau-
ma to head; some of the medications (e.g., ethambutol and 
anti-retroviral therapy) are risk factors, which may exert an 
influence on LHON penetrance (4). LHON plus syndrome 
is an atypical form of the syndrome which includes variable 
CNS involvements.
In these patients, optic neuropathy is accompanied by 
other neurological manifestations such as various move-
ment disorders, dystonia, tremor, parkinsonism, cerebellar 
ataxia, myoclonus, lesions of the basal ganglia, a Leigh-like 
syndrome, cerebellar atrophy, migraine, mental retardation, 
epilepsy, peripheral neuropathy, and some forms of skeletal 
deformities (1, 5).
There were few cases of LHON plus syndrome in liter-
ature, one of the first reports of presentation of LHON and 
the other neurological symptoms was in 1995 by Nikoske-
lainen EK (6). In this study, the authors introduce patients 
with LHON with some different movement disorders (dys-
tonia and parkinsonism and MS-like presentations). In the 
latter case reports, ataxia (7) dystonia (8,9) and seizure (2) 
were reported as some other CNS manifestations of the dis-
ease.
Juvenile-onset encephalopathy, psychiatric disturbances, 
and regression as well as seen in our patient, are the other 
presentations that are very confusing for diagnosis (10). The 
overlap between LHON and MS-like symptoms (LHON-MS, 
Harding disease) is the other association and presentation of 
the disease (11).
Our patient was an adolescent with classic ophthalmo-
logic features of LHON accompanied by refractory seizure, 
progressive cognitive deficit, and mental retardation. Ac-
cording to his past medical history, physical examinations 
and para clinical findings LHON plus syndrome was diag-
nosed. The management of these patients remains largely 
supportive and symptomatic (12).
CONCLUSION
LHON plus syndrome is a rare condition with no definite 
treatment. Early diagnosis and ruling out treatable condi-
tions are very important points in these patients.
ACKNOWLEDGMENTS
We have to thank all the employees of Shiraz University of 
Medical Sciences how help us to provide this article
AUTHORS CONTRIBUTION
All authors contributed equally in this study
REFERENCES
1. Carelli V, Achilli A, Valentino ML, Rengo C, Semino O, 
Pala M, et al. Haplogroup effects and recombination of 
mitochondrial DNA: novel clues from the analysis of 
Leber hereditary optic neuropathy pedigrees. Am J Hum 
Genet. 2006;78:564–574.
2. Guerriero S, Vetrugno M, Ciracì L, Artuso L, 
Dell’aglio R, Petruzzella V. Bilateral progressive visual 
loss in an epileptic, mentally retarded boy.Middle East 
Afr J Ophthalmol. 2011 Jan;18(1):67-70.
3. Sadun AA, Carelli V, Salomao SR, Berezovsky A, 
Quiros PA, Sadun F, et al. Extensive investigation of 
a large Brazilian pedigree of 11778 haplogroup J Leb-
er hereditary optic neuropathy. Am J Ophthalmol. 
2003;136:231–8.
4. Sadun AA, Carelli V, Salomao SR, Berezovsky A, 
Quiros PA, Sadun F, et al. Extensive investigation of 
a large Brazilian pedigree of 11778 haplogroup J Leb-
er hereditary optic neuropathy. Am J Ophthalmol. 
2003;136:231–8.
Figure 1. Funduscopy  showed retinitis pigmentosa
Leber Hereditary Optic Neuropathy 111
5. Nakaso K, Adachi Y, Fusayasu E, Doi K, Imamura K, 
Yasui K, et al, Leber’s Hereditary Optic Neuropathy 
with Olivocerebellar Degeneration due to G11778A and 
T3394C Mutations in the Mitochondrial DNA. J Clin 
Neurol. 2012 Sep;8(3):230-4.
6. Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, 
Lamminen T, Sonninen P et al. Leber’s “plus”: neuro-
logical abnormalities in patients with Leber’s heredi-
tary optic neuropathy.J Neurol Neurosurg Psychiatry. 
1995 Aug;59(2):160-4.
7. Murakami T, Mita S, Tokunaga M, Maeda H, Ueyama H, 
Kumamoto T et al. Hereditary cerebellar ataxia with 
Leber’s hereditary optic neuropathy mitochondrial DNA 
11778 mutation.J Neurol Sci. 1996 Oct;142(1-2):111-3.
8. Abu-Amero KK, Bosley TM, Bohlega S, McLean D. 
Complex I respiratory defect in LHON plus dystonia 
with no mitochondrial DNA mutation. Br J Ophthalmol. 
2005 Oct;89(10):1380-1.
9. Kim IS1, Ki CS, Park KJ. Pediatric-onset dystonia as-
sociated with bilateral striatal necrosis and G14459A 
mutation in a Korean family: a case report. J Ko-
rean Med Sci. 2010 Jan;25(1):180-4. doi: 10.3346/
jkms.2010.25.1.180. Epub 2009 Dec 26.
10. Yu-Wai-Man P, Griffiths PG, Chinnery PF.Mitochon-
drial optic neuropathies - disease mechanisms and 
therapeutic strategies. Prog Retin Eye Res. 2011 Mar; 
30(2):81-114.
11. Pfeffer G, Burke A, Yu-Wai-Man P, Compston DA, 
Chinnery PF, Clinical features of MS associated with 
Leber hereditary optic neuropathy mtDNA mutations.
Neurology. 2013 Dec 10; 81(24):2073-81.
12. Yu-Wai-Man P, Votruba M, Burté F, La Morgia C, Bar-
boni P, Carelli V, A neurodegenerative perspective on 
mitochondrial optic neuropathies. Acta Neuropathol. 
2016 Dec;132(6):789-806. Epub 2016 Sep 30.
